Literature DB >> 25463544

Hepatic hepcidin expression is decreased in cirrhosis and HCC.

Sonja M Kessler1, Ahmad Barghash2, Stephan Laggai3, Volkhard Helms2, Alexandra K Kiemer3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25463544     DOI： 10.1016/j.jhep.2014.10.046

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  13 in total

1.  Hepatic Smad7 overexpression causes severe iron overload in mice.

Authors:  Dilay Lai; Feng Teng; Seddik Hammad; Julia Werle; Thorsten Maas; Andreas Teufel; Martina U Muckenthaler; Steven Dooley; Maja Vujić Spasić
Journal:  Blood       Date:  2017-12-13       Impact factor: 22.113

2.  Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia.

Authors:  Kathryn R Michels; Zhimin Zhang; Alexandra M Bettina; R Elaine Cagnina; Debora Stefanova; Marie D Burdick; Sophie Vaulont; Elizabeta Nemeth; Tomas Ganz; Borna Mehrad
Journal:  JCI Insight       Date:  2017-03-23

3.  Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma.

Authors:  Issei Saeki; Naoki Yamamoto; Takahiro Yamasaki; Taro Takami; Masaki Maeda; Koichi Fujisawa; Takuya Iwamoto; Toshihiko Matsumoto; Isao Hidaka; Tsuyoshi Ishikawa; Koichi Uchida; Kenji Tani; Isao Sakaida
Journal:  World J Gastroenterol       Date:  2016-10-28       Impact factor: 5.742

4.  Dietary Iron Supplementation Alters Hepatic Inflammation in a Rat Model of Nonalcoholic Steatohepatitis.

Authors:  Machi Atarashi; Takeshi Izawa; Rena Miyagi; Shoko Ohji; Ai Hashimoto; Mitsuru Kuwamura; Jyoji Yamate
Journal:  Nutrients       Date:  2018-02-04       Impact factor: 5.717

5.  Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease.

Authors:  Bernhard Scheiner; Georg Semmler; Florian Maurer; Philipp Schwabl; Theresa A Bucsics; Rafael Paternostro; David Bauer; Benedikt Simbrunner; Michael Trauner; Mattias Mandorfer; Thomas Reiberger
Journal:  Liver Int       Date:  2019-09-13       Impact factor: 5.828

6.  Iron elevates mesenchymal and metastatic biomarkers in HepG2 cells.

Authors:  Kosha J Mehta; Paul A Sharp
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

7.  MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis.

Authors:  Iryna Kindrat; Volodymyr Tryndyak; Aline de Conti; Svitlana Shpyleva; Thilak K Mudalige; Tetyana Kobets; Anna M Erstenyuk; Frederick A Beland; Igor P Pogribny
Journal:  Oncotarget       Date:  2016-01-12

8.  Correlation of serum hepcidin levels with disease progression in hepatitis B virus-related disease assessed by nanopore film based assay.

Authors:  Jing Wang; Ailian Dong; Gang Liu; Gregory J Anderson; Tony Y Hu; Jian Shi; Yulin Hu; Guangjun Nie
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

Review 9.  Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications.

Authors:  Driton Vela; Zana Vela-Gaxha
Journal:  Exp Mol Med       Date:  2018-02-02       Impact factor: 8.718

10.  HAMP Downregulation Contributes to Aggressive Hepatocellular Carcinoma via Mechanism Mediated by Cyclin4-Dependent Kinase-1/STAT3 Pathway.

Authors:  Ying Shen; Xin Li; Yanwei Su; Shaikh Atik Badshah; Bin Zhang; Yanru Xue; Peng Shang
Journal:  Diagnostics (Basel)       Date:  2019-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.